About the Author:
Justin Stebbing is a Professor of Cancer Medicine and Oncology at Imperial College, London, and Editor-in-Chief of Oncogene. He sits on a wide variety of scientific advisory boards, and has published over 600 papers. His treatment of cancer patients and his attempt to extend the quality and quantity of life has been called ‘life-changing’. At the start of the pandemic, with his medical work restricted, he turned to working on SARS-CoV-2. His first paper on the dual anti-cytokine and anti-viral properties of baricitinib was accepted by the Lancet within 3 minutes and published on the same day. Since mid-January 2020 he has written a daily COVID blog.